Nasaclip250New Device Provides an Effective, Hands-Free Solution to Stop Nosebleeds in Children and Adults

Adult and Pediatric NasaClip Sizes Provide Easy-To-Use Options for Chronic Nosebleed Sufferers, Healthcare Professionals, Parents, and Schools; First Available, U.S. Food and Drug Administration Registered Device with Age-Appropriate Sizing for Patients Aged 2 and Older

BALTIMORE, MD. (PRWEB) JULY 11, 2023

NasaClip, Inc., a Baltimore-based medical device company focused on improving the lives of patients with nosebleeds and the healthcare professionals who treat them today introduced the NasaClip, an easy-to-use device that provides constant, comfortable hands-free compression combined with intranasal sponges to stop nosebleeds quickly. NasaClip comes in an adult size for ages 14+, and pediatric size for children ages 2 to 13. It is the first nosebleed rescue device that provides adjustable nasal compression for children and adults and is registered with the U.S. Food and Drug Administration (FDA).

Using NasaClip is as easy as inserting two soft intranasal sponges and adjusting the attached clip to provide the appropriate nasal compression over the nostrils targeting Kiesselbach’s plexus, the origin of most anterior nosebleeds. This convenient, painless, and hands-free approach reduces mess and hassle for parents, school nurses, caregivers, athletic trainers, coaches, and medical professionals who can now treat children and adults at any time in any environment.

“NasaClip provides a new and easy-to-use option to stop nosebleeds quickly, affordably, and with hands-free technology. It is also the first nosebleed rescue device of its kind that combines compression with intranasal sponges that can be medicated, making it an essential item to consider having on hand in hospitals, clinics, daycare centers, schools, athletic fields, and homes,” said Elizabeth Clayborne M.D., Founder and CEO of NasaClip. “Nosebleeds can happen anywhere – at school, during a sports game, in an airport, or at home – and range in severity from a nuisance to recurring. No matter the cause, stopping the bleeding requires immediate and constant compression, which NasaClip is designed to provide.”

Approximately 60% of people will experience at least one nosebleed in their lifetime. And yearly, there are more than 500,000 ER visits for nosebleeds in the U.S. alone. Nosebleeds occur most commonly in children aged 2 to 10 years old and in older adults from 55 to 80 years old, especially those on blood thinners. More than half of children will experience a nosebleed by the time they are 10 years old, with 9% of children reported to have recurrent episodes. Nosebleeds are often defined as recurrent if occur five or more times in a 12-month period.

NasaClip’s versatile sizes and easy-to-use design also has the power to positively impact patients’ quality of care by empowering nurses and other medical professionals to treat nosebleeds quickly, without a doctor’s care. To learn more about the device, please visit NasaClip.com.

About NasaClip:

NasaClip was founded in 2015 by Dr. Elizabeth Clayborne and two Co-founders at George Washington University. She and her team have been working diligently to raise money for the company, engineer the device and launch it into the market. Dr. Clayborne continues work as an Adjunct Assistant Professor of Emergency Medicine at the University of Maryland School of Medicine, is a mother of 2, and frequents national television networks as a healthcare expert. She believes her story as a Founder and CEO who is a Black woman has called much-needed attention to the dearth of funding that is directed to companies founded by women and people of color. She is determined to serve as an example of Black excellence and inspire others who come from underrepresented backgrounds to pursue their entrepreneurial dreams. Dr. Clayborne developed the NasaClip nosebleed rescue device, to empower individuals and caretakers and provide them with the necessary tool to stop nosebleeds quickly anywhere at any time. Follow us on Instagram, Facebook, Twitter and LinkedIn.

Visit NasaClip.com for more information.